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Invasive aspergillosis (IA) is a life-threatening infection due to Aspergillus fumigatus and
other Aspergillus spp. Drugs targeting the fungal cell membrane (triazoles, amphotericin
B) or cell wall (echinocandins) are currently the sole therapeutic options against IA.
Their limited efficacy and the emergence of resistance warrant the identification of
new antifungal targets. Histone deacetylases (HDACs) are enzymes responsible of the
deacetylation of lysine residues of core histones, thus controlling chromatin remodeling
and transcriptional activation. HDACs also control the acetylation and activation status of
multiple non-histone proteins, including the heat shock protein 90 (Hsp90), an essential
molecular chaperone for fungal virulence and antifungal resistance. This review provides an
overview of the different HDACs in Aspergillus spp. as well as their respective contribution
to total HDAC activity, fungal growth, stress responses, and virulence. The potential of
HDAC inhibitors, currently under development for cancer therapy, as novel alternative
antifungal agents against IA is discussed.
Keywords: lysine deacetylases, Aspergillus fumigatus, trichostatin A, heat shock protein 90, antifungal therapy,
antifungal resistance
INTRODUCTION
The filamentous fungus Aspergillus fumigatus is the primary cause
of invasive aspergillosis (IA), a frequent and life-threatening
infection in immunosuppressed patients. Novel therapeutic
approaches of IA are needed to overcome emerging resistance
to azoles, used as first-line therapy, and the toxicity or limited
efficacy of second-line treatments such as amphotericin B and
echinocandins. Moreover, other Aspergillus spp. with less suscep-
tibility to current antifungal drugs (A. flavus, A. terreus, A. ustus)
account for a substantial proportion of IA.
The pathogenesis of IA relies on multiple microbial and host
factors. At the pathogen level, morphogenetic changes (germina-
tion, hyphal growth), thermal and metabolic adaptation to the
human body, metabolite production and resistance to antifun-
gal drugs are all determinants contributing to the virulence of
A. fumigatus (Tekaia and Latge, 2005; Kwon-Chung and Sugui,
2013). Adaptation to environmental conditions involves processes
of chromatin remodeling and transcriptional regulation. The
modulation of gene expression depends on the packaging of DNA
by core histones constituting the dynamic structure of chromatin.
Direct DNA methylation and post-translational modifications
of histones (such as acetylation and methylation) are impor-
tant for conformational changes and transcriptional regulation
(Brosch et al., 2008). Histone acetyltransferases (HATs) and his-
tone deacetylases (HDACs, also referred to as lysine deacety-
lases, KDACs) are the enzymes responsible for the reversible
process of acetylation (i.e., addition of an acetyl group to the
ε-amino group of a lysine residue) and deacetylation of core
histones, respectively. Moreover, these enzymes are also involved
in the functional regulation of proteins other than core his-
tones, including the heat shock protein 90 (Hsp90), an essential
molecular chaperone for proper protein folding and maturation
(Yu et al., 2002). In fungi, Hsp90 was shown to play a crucial
role in morphogenetic changes, stress adaptation, virulence, and
antifungal resistance, and thus represents an attractive antifun-
gal target (Cowen, 2013; Lamoth et al., 2014a). Acetylation of
Hsp90 results in impaired Hsp90 function, while HDACs reverse
this process and activate the chaperone (Robbins et al., 2012;
Lamoth et al., 2014c). Thus, HDACs play a role in fungal vir-
ulence by controlling the expression and function of multiple
proteins, including chaperones and secondary metabolites that
are important for basal growth or stress adaptation, either at the
transcriptional level (by deacetylation of core histones and reg-
ulation of their expression) or at the post-translational level (by
deacetylation and activation of the protein; Figure 1). This review
will focus on HDACs and their link with Hsp90. The potential
of HDAC inhibitors as novel antifungal therapies of IA will be
discussed.
HDACs IN Aspergillus
Histone deacetylases are categorized in three families: (1) the zinc-
dependent or “classical” HDACs (including classes 1 and 2, as
well as HOS3-like HDACs in fungi and class 4 in other eukary-
otes), (2) the NAD+-dependent SIR2-like HDACs or sirtuins
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FIGURE 1 | Schematic representation of the role of the classical
histone deacetylases (HDACs) in Aspergillus fumigatus. Classical
HDACs in Aspergillus spp. include RpdA and HdaA, contributing to the
major part of total HDAC activity, and HosA and HosB, contributing to a
minor part. RpdA and HosA belong to class 1. HdaA belongs to class 2.
HosB was proposed as the only member of a distinct class. In the nucleus,
HDACs deacetylate core histones, which results in chromatin remodeling
and transcriptional regulation of the expression of secondary metabolites
and multiple proteins. They also regulate the function of other nuclear
proteins involved in DNA replication, DNA repair, nuclear transport, or cell
cycle. HDACs also deacetylate and control the activation of multiple
cytosolic proteins, including the heat shock protein 90 (Hsp90), which is
essential for fungal growth and stress responses. HDACs thus contribute to
fungal development and environmental adaptation in multiple ways.
Trichostatin A and other hydroxamate analogs inhibit both class 1 and class
2 HDACs (with the exception of HosB) displaying antifungal activity against
A. fumigatus and potentiating (<) the effect of cell wall inhibitors such as
the echinocandins. MGCD290 is a specific inhibitor of HosA with poor
intrinsic antifungal activity, but potentiates the effect of cell membrane
inhibitors such as the azoles.
(also referred as class 3), and (3) the HD2-like enzymes (found
exclusively in plants; Trojer et al., 2003; Brosch et al., 2008).
CLASSICAL HDACs
Five classical fungal HDACs have been characterized in the model
yeast Saccharomyces cerevisiae and divided into two classes, the
class 1 or RPD3-type HDACs (including RPD3, HOS1, and
HOS2) and the class 2 or HDA1-type HDACs (HDA1; Rundlett
et al., 1996; Kurdistani and Grunstein, 2003). HOS3 is a fungal-
specific HDAC, representing a third group distinct from the
other ones, albeit initially classified within class 2 (Carmen et al.,
1999). Our knowledge of classical HDACs in filamentous fungi
is essentially derived from studies in A. nidulans, A. oryzae, and
in plant pathogenic fungi (Brosch et al., 2008). In A. nidulans,
two class 1 enzymes have been identified, RpdA and HosA, with
high sequence similarity to yeast RPD3 and HOS2, respectively,
except for a 200-amino acid C-terminal extension specific to
A. nidulans RpdA (Graessle et al., 2000). There is no HOS1
Aspergillus ortholog. HdaA was characterized as the yeast HDA1
(class 2) ortholog (Trojer et al., 2003). A HOS3 ortholog, HosB,
was also identified (Trojer et al., 2003). Putative orthologs for
all these enzymes were identified in A. oryzae and A. fumigatus
(Trojer et al., 2003; Kawauchi et al., 2013).
Both RpdA (class 1) and HdaA (class 2), acting in multiprotein
complexes, were shown to contribute to the majority of total
HDAC activity in A. nidulans, with HdaA being the predominant
one (Trojer et al., 2003; Tribus et al., 2005). In contrast, HosA and
HosB contribute to a negligible portion of total HDAC activity.
SIRTUINS
The sirtuins are conserved eukaryotic enzymes requiring nicoti-
namide adenine dinucleotide (NAD+) for their activity. Their role
in promoting longevity has generated great interest. In S. cere-
visiae, SIR2 silences transcription at the silent mating type loci
and reduces ribosomal DNA recombination and rDNA extrachro-
mosomal circles production, resulting in an extended life span
(Wierman and Smith, 2014). S. cerevisiae has four additional
SIR2-like sirtuins, HST1-4 (Wierman and Smith, 2014). Little is
known about sirtuins in filamentous fungi. Putative SIR2-type
and HST-type orthologs were identified by sequence alignment
(Brosch et al., 2008). In A. nidulans, it is evident that a pro-
portion of the total HDAC activity, albeit less important than
that attributed to classical HDACs, is NAD+-dependent and thus
attributable to sirtuins (Trojer et al., 2003).
ROLE OF HDACs IN Aspergillus GROWTH AND
ENVIRONMENTAL ADAPTATION
HdaA
Genetic deletion of hdaA, the major contributor to total HDAC
activity, was performed in A. nidulans, A. oryzae and A. fumigatus
(Tribus et al., 2005; Lee et al., 2009; Kawauchi et al., 2013).
A growth defect was only observed in the A. fumigatus ∆hdaA
strain, but did not result in decreased virulence in a murine
model of IA (Lee et al., 2009). Altered responses to osmotic
or oxidative stress were observed in A. nidulans and A. oryzae
(Tribus et al., 2005; Kawauchi and Iwashita, 2014). HdaA was also
found to have a role in the production of secondary metabolites,
which was associated with the transcriptional regulation of two
telomere-proximal secondary metabolic gene clusters (the sterig-
matocystin and penicillin clusters; Shwab et al., 2007; Lee et al.,
2009).
RpdA
While RpdA was found to be less important than HdaA for total
HDAC activity (Trojer et al., 2003) and could be deleted in yeasts
(Robbins et al., 2012), it was found to be essential in A. nidulans
and A. oryzae, as well as in the plant pathogenic filamentous
fungus Magnaporthe oryzae (Izawa et al., 2009; Tribus et al.,
2010; Kawauchi et al., 2013). Genetic repression was achieved
in A. nidulans by substitution of the native rpdA promoter by
the alcohol dehydrogenase or xylanase inducible promoters and
resulted in an important growth and sporulation defect (Tribus
et al., 2010). Truncations in the C-terminal portion of A. nidulans
RpdA showed that a fungal-specific conserved motif was essential
for the catalytic activity of the enzyme and for fungal viability
(Tribus et al., 2010). Heterologous expression of the C-terminal
motif of A. fumigatus RpdA was able to restore RpdA functionality
in A. nidulans, suggesting a common crucial role of this conserved
region among Aspergillus spp and possibly other filamentous
fungi.
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HosA AND HosB
Despite their minor contribution to total HDAC activity in
Aspergillus spp, functional analyses suggest that HosA (yeast
HOS2) is important for growth and virulence in filamen-
tous fungi. Its deletion in A. oryzae had more impact on
radial growth and sporulation than the hdaA deletion and
also resulted in altered stress responses (Kawauchi et al., 2013;
Kawauchi and Iwashita, 2014). In plant pathogenic fungi (Fusar-
ium graminearum, M. oryzae, Cochliobolus carbonum), HOS2-
related enzymes appear as the most important class 2 HDAC for
vegetative growth, sporulation and virulence (Baidyaroy et al.,
2001; Izawa et al., 2009; Ding et al., 2010; Li et al., 2011). Indeed,
Hos2 (HosA ortholog) was found to contribute to an important
part of total HDAC activity in M. oryzae (Ding et al., 2010), which
was not the case for A. nidulans (Trojer et al., 2003).
Genetic deletion of hosB (the HOS3 type HDAC) did not
result in significant phenotypic consequences in A. nidulans and
A. oryzae, confirming its minor contribution to total HDAC
activity although this HDAC seems to have some additive role
in metabolite production (Tribus et al., 2005; Shwab et al., 2007;
Kawauchi et al., 2013; Kawauchi and Iwashita, 2014).
OTHER HDACs
Genetic deletion of 6 sirtuins of A. oryzae was performed and
only HstD/AoHst4 was associated with a significant role in fungal
growth, sporulation, stress responses and production of sec-
ondary metabolites via the regulation of LaeA (Kawauchi et al.,
2013; Kawauchi and Iwashita, 2014).
THE KEY ROLE OF HDACs IN REGULATING HEAT SHOCK
PROTEIN 90
In addition to histones, an increasing number of proteins have
been identified as substrates of HDACs, leading to the use of the
more general terminology of lysine deacetylases (KDAC; Glozak
et al., 2005; Choudhary et al., 2009). Many of these proteins
belong to categories that are important for fungal growth and
virulence, such as transcription factors, cytoskeletal proteins, and
molecular chaperones (Choudhary et al., 2009). Among them,
Hsp90 emerges as a key player for which the relationship to
HDACs has been recently described. Hsp90 was shown to be
essential for fungal survival and to be an important trigger
of antifungal resistance to both azole and echinocandin classes
and possibly to amphotericin B (Cowen and Lindquist, 2005;
Cowen et al., 2009; Singh et al., 2009; Lamoth et al., 2012,
2014b; Blum et al., 2013). In A. fumigatus, Hsp90 governs
the basal resistance to echinocandins including the paradoxi-
cal effect of caspofungin, a compensatory mechanism of the
cell wall resulting in decreased caspofungin antifungal activity
at increased concentrations (Wiederhold, 2007; Lamoth et al.,
2014b). Pan-HDAC inhibitors (depsipeptide, hydroxamic acid
analogs) induced acetylation of Hsp90 in human cancer cells,
which prevented the binding of Hsp90 to client proteins (Yu et al.,
2002; Nimmanapalli et al., 2003). Human HDAC6, a class 2b
HDAC related to fungal HDA1, deacetylates Hsp90 and mod-
ulates its activity (Bali et al., 2005; Kovacs et al., 2005). Other
HDACs of class 2, such as HDAC1 and HDAC10, are also involved
in the acetylation of Hsp90 in human (Park et al., 2008; Zhou
et al., 2008). Lysine 294 (K294) of human Hsp90 was identified as
a key acetylation site for Hsp90 function (Scroggins et al., 2007).
Several additional acetylation sites have been recovered in human
Hsp90 (Yang et al., 2008; Mollapour and Neckers, 2012).
The role of HDACs in the control of fungal Hsp90 was first
demonstrated in S. cerevisiae by genetic or pharmacologic inhi-
bition of RPD3 and HDA1, which resulted in the abrogation
of Hsp90-dependent azole resistance and impaired interaction
of Hsp90 with multiple client proteins (Robbins et al., 2012).
Lysine 27 (K27) was found to be acetylated in yeast Hsp90 after
deletion of both HDA1 and RPD3 (Robbins et al., 2012). We
detected acetylation at K271 (K294 in human) in A. fumigatus
Hsp90 after treatment with the HDAC inhibitor trichostatin A
(TSA; Lamoth et al., 2014c). Mutational analyses actually suggest
that both K27 and K271 (K270 in yeast) are important for Hsp90
function. Mutations of both sites resulted in impaired Hsp90
function in S. cerevisiae and A. fumigatus and were associated
with decreased virulence in a murine model of IA (Robbins et al.,
2012; Lamoth et al., 2014c). However, while K270 appears to be
the predominant site in yeast, K27 seems to be more important in
A. fumigatus. An acetylation-mimetic mutation (lysine to alanine)
of this residue was sufficient to affect Hsp90 function. This effect
could be reversed by a deacetylation-mimetic mutation (lysine to
arginine) of K27, suggesting that this site must be deacetylated for
proper Hsp90 function (Lamoth et al., 2014c). Mutation of K27
alone also resulted in increased susceptibility to both caspofungin
and voriconazole in A. fumigatus (Lamoth et al., 2014c). However,
neither K27 nor K270 mutations were able to decrease azole
resistance of an erg3 mutant of S. cerevisiae, while this effect could
be achieved by treatment with TSA and by genetic deletion of both
RPD3 and HDA1 (Robbins et al., 2012). Thus, the role of HDACs
in governing Hsp90 function in antifungal resistance may differ
among fungi.
THE ANTIFUNGAL ACTIVITY OF HDAC INHIBITORS
The fact that TSA, an organic antibiotic produced by Strepto-
myces hygroscopicus, and its hydroxamate analogs display some
antifungal activity is well-known (Tsuji et al., 1976). Although
these compounds are known to be broad-spectrum inhibitors
of both class 1 and 2 HDACs (with the exception of HOS3-
like HDAC), their precise mode of action against fungi remains
poorly elucidated. HDAC inhibitors were shown to consider-
ably modify the profile of secondary metabolites produced by
Aspergillus spp., although the impact of this effect on virulence
is unclear (Henrikson et al., 2009; Konig et al., 2013). Recent
studies suggest that their antifungal effect mainly results from
the acetylation and inhibition of Hsp90 (Robbins et al., 2012;
Lamoth et al., 2014c). HDACs inhibitors have raised considerable
interest because of their potential as anticancer therapy and are
undergoing rapid development in the pharmaceutical industry
(West and Johnstone, 2014). Some of them also display anti-
parasitic activity against Plasmodium falciparum and Toxoplasma
gondii (Strobl et al., 2007; Trenholme et al., 2014).
Trichostatin A has minimal antifungal activity against C. albi-
cans, although it potentiates the activity of azoles by a mechanism
which is supposed to be essentially mediated via Hsp90 inhibition
and associated with loss in the upregulation of ERG and CDR
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genes in response to azoles (Smith and Edlind, 2002; Robbins
et al., 2012). TSA alone appears to be more active against molds.
We have observed a 50 and >90% growth inhibition of the
wild-type A. fumigatus strain AF293 at TSA concentrations of 1
and 4 µg/ml, respectively (Lamoth et al., 2014c). TSA also had
variable antifungal activity against clinical isolates of Aspergillus
spp. and other pathogenic non-Aspergillus molds, and was par-
ticularly active against the azole-resistant A. ustus and the multi-
resistant Scedosporium prolificans isolates (Lamoth et al., 2015).
TSA also exhibited synergistic activity with caspofungin against
some Aspergillus spp. and with the Hsp90 inhibitor geldanamycin
against Rhizopus spp. (Lamoth et al., 2014c, 2015). The differential
effect of TSA against C. albicans and A. fumigatus may be related
to different patterns of HDAC activity in these fungi. The better
antifungal activity of TSA against A. fumigatus is consistent with
the finding that genetic compromise of hdaA and rpdA had a
much greater impact on fungal growth and survival in Aspergillus
spp. compared to deletion of their orthologs in yeast (Lee et al.,
2009; Tribus et al., 2010; Robbins et al., 2012).
The effect of TSA against A. fumigatus had some similitude
with that observed after acetylation-mimetic mutations or genetic
repression of hsp90, including a growth and conidiation defect
and hypersensitivity to geldanamycin (Lamoth et al., 2014c).
Moreover, TSA enhanced the antifungal activity of caspofungin
and abolished the paradoxical effect, which is a hallmark of
Hsp90 inhibition. However, TSA did not potentiate the effect of
voriconazole against A. fumigatus, which contrasts with previous
reports in yeasts showing a positive interaction of TSA with
azoles but not with echinocandins (Smith and Edlind, 2002;
Robbins et al., 2012). Indeed, differences in Hsp90-dependent
pathways of azole and echinocandin resistance between C. albi-
cans and A. fumigatus have been previously outlined (Lamoth
et al., 2014a). Overall, these data support that the antifungal
effect of TSA is largely mediated via indirect inhibition of Hsp90.
However, considering the role of HDACs in transcriptional
regulation, metabolite production, and activation of multiple
non-histone proteins, it is probable that other mechanisms are
involved.
Trichostatin A was well tolerated in pharmacokinetic murine
models, but is rapidly metabolized (half-life of 5–10 min; Sander-
son et al., 2004). Numerous novel HDAC inhibitors are cur-
rently under investigation for the treatment of cancer in clinical
and preclinical trials (West and Johnstone, 2014). Vorinostat
(suberoylanilide hydroxamic acid, SAHA) is a TSA analog which
has an extended half-life and has been approved by the food
and drug administration (FDA) for the treatment of cutaneous
T cell lymphoma (Duvic et al., 2007). The antifungal activity of
SAHA and other hydroxamate analogs remains to be investigated.
Although these compounds have been well tolerated in clinical tri-
als (Duvic et al., 2009; Fouladi et al., 2010), some rare and possibly
dose-dependent hematologic adverse events (granulocytopenia,
thrombocytopenia) may counterbalance their potential benefit in
the setting of invasive fungal diseases.
A selective HDAC inhibitor of fungal HOS2, MGCD290
(MethylGene Inc., Montreal, QC, Canada) was tested against clin-
ical isolates of yeasts and molds (Pfaller et al., 2009). MGCD290
alone displayed some in vitro antifungal activity against Candida
spp. and other yeasts, but was inactive against filamentous fungi.
Most importantly, MGCD290 exhibited synergism with azoles
(fluconazole, voriconazole and posaconazole) against both yeast
and mold species. The combination of MGCD290 and flucona-
zole was recently tested for the treatment of vulvovaginal can-
didiasis in a randomized phase II study but did not demonstrate
a benefit compared to fluconazole monotherapy (Augenbraun
et al., 2013).
CONCLUSION AND PERSPECTIVES
In filamentous fungi, HDACs are involved in multiple processes
contributing to virulence via transcription control and functional
regulation of important proteins (Figure 1). HDAC inhibition
thus represents an interesting alternative antifungal approach
to current strategies targeting the cell wall or membrane. The
antifungal effect of the HDAC inhibitor TSA and its analogs
against A. fumigatus seems to be mainly achieved via the acety-
lation and inhibition of Hsp90 (Lamoth et al., 2014c). This
molecular chaperone is essential for virulence and triggers stress
responses and resistance to the most important antifungal classes
(Lamoth et al., 2014a). HDAC inhibitors have demonstrated a
potential as antifungal monotherapy in vitro, as well as adjunc-
tive therapies to enhance the effect of existing drugs against
A. fumigatus (Pfaller et al., 2009; Lamoth et al., 2014c, 2015).
Their potential as anti-cancer therapy is generating an intense
research activity in drug development with several compounds
currently investigated in clinical and pre-clinical trials (West
and Johnstone, 2014). There is a great opportunity to harness
these recent advances, and gain in-depth understanding of fungal
HDACs, to pursue novel and more effective antifungal strategies
against IA.
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